Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cavazzoni

Showing results (221-230 of 308) with videos related to

Pageof 31
Sort By:
Bioorganic & Medicinal Chemistry|July 30, 2010
Synthesis and biological evaluation of tetracyclic fluoroquinolones as antibacterial and anticancer agentsSalah A Al-Trawneh, Jalal A Zahra, Marwan R Kamal, et al.
Neoplasia (New York, N.Y.)|January 30, 2013
Molecular mechanisms underlying the antitumor activity of 3-aminopropanamide irreversible inhibitors of the epidermal growth factor receptor in non-small cell lung cancerElena Galvani, Elisa Giovannetti, Francesca Saccani, et al.
The Journal of Clinical Psychiatry|February 17, 2010
Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitationStephen R Marder, Sebastian Sorsaburu, Eduardo Dunayevich, et al.
Targeted Oncology|October 19, 2023
Intrinsic Resistance to Osimertinib in EGFR Mutated NSCLC Cell Lines Induced by Alteration in Cell-Cycle RegulatorsFrancesco Volta, Silvia La Monica, Alessandro Leonetti, et al.
ANZ Journal of Surgery|June 5, 2025
Non-Retrieval and Non-Utilisation of Deceased Donor Kidneys for Transplantation: An Australian Cohort StudyRachel B Cutting, Nicole L De La Mata, Animesh Singla, et al.
Pediatric Nephrology (Berlin, Germany)|September 19, 2024
Effect of perioperative management on early graft function in living donor paediatric kidney transplantationJennifer Q J Zhang, Elena Cavazzoni, Anne M Durkan, et al.
Cancers|December 11, 2022
CDK4/6 Inhibition Enhances the Efficacy of Standard Chemotherapy Treatment in Malignant Pleural Mesothelioma CellsRita Terenziani, Maricla Galetti, Silvia La Monica, et al.
Critical Care Medicine|December 29, 2010
Targeted temperature management in critical care: a report and recommendations from five professional societiesMark E Nunnally, Roman Jaeschke, Geoffrey J Bellingan, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 6, 2017
Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell linesSilvia La Monica, Daniele Cretella, Mara Bonelli, et al.
Cancers|December 30, 2020
Efficacy of the CDK4/6 Dual Inhibitor Abemaciclib in EGFR-Mutated NSCLC Cell Lines with Different Resistance Mechanisms to OsimertinibSilvia La Monica, Claudia Fumarola, Daniele Cretella, et al.
Pageof 31

Showing results (221-230 of 308) with videos related to

Sort By:
Pageof 31
Bioorganic & Medicinal Chemistry|July 30, 2010
Synthesis and biological evaluation of tetracyclic fluoroquinolones as antibacterial and anticancer agentsSalah A Al-Trawneh, Jalal A Zahra, Marwan R Kamal, et al.
Neoplasia (New York, N.Y.)|January 30, 2013
Molecular mechanisms underlying the antitumor activity of 3-aminopropanamide irreversible inhibitors of the epidermal growth factor receptor in non-small cell lung cancerElena Galvani, Elisa Giovannetti, Francesca Saccani, et al.
The Journal of Clinical Psychiatry|February 17, 2010
Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitationStephen R Marder, Sebastian Sorsaburu, Eduardo Dunayevich, et al.
Targeted Oncology|October 19, 2023
Intrinsic Resistance to Osimertinib in EGFR Mutated NSCLC Cell Lines Induced by Alteration in Cell-Cycle RegulatorsFrancesco Volta, Silvia La Monica, Alessandro Leonetti, et al.
ANZ Journal of Surgery|June 5, 2025
Non-Retrieval and Non-Utilisation of Deceased Donor Kidneys for Transplantation: An Australian Cohort StudyRachel B Cutting, Nicole L De La Mata, Animesh Singla, et al.
Pediatric Nephrology (Berlin, Germany)|September 19, 2024
Effect of perioperative management on early graft function in living donor paediatric kidney transplantationJennifer Q J Zhang, Elena Cavazzoni, Anne M Durkan, et al.
Cancers|December 11, 2022
CDK4/6 Inhibition Enhances the Efficacy of Standard Chemotherapy Treatment in Malignant Pleural Mesothelioma CellsRita Terenziani, Maricla Galetti, Silvia La Monica, et al.
Critical Care Medicine|December 29, 2010
Targeted temperature management in critical care: a report and recommendations from five professional societiesMark E Nunnally, Roman Jaeschke, Geoffrey J Bellingan, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 6, 2017
Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell linesSilvia La Monica, Daniele Cretella, Mara Bonelli, et al.
Cancers|December 30, 2020
Efficacy of the CDK4/6 Dual Inhibitor Abemaciclib in EGFR-Mutated NSCLC Cell Lines with Different Resistance Mechanisms to OsimertinibSilvia La Monica, Claudia Fumarola, Daniele Cretella, et al.
Pageof 31